Overview

A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma

Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
A phase Ib study of Olaparib with concomitant radiotherapy in locally advanced/unresectable soft-tissue sarcoma.
Phase:
Phase 1
Details
Lead Sponsor:
Institut Bergonié
Collaborator:
National Cancer Institute, France
Treatments:
Olaparib